Latest News from NHEM

Podcast Healthonomics Talks - <p><strong data-end="116" data-start="57">Nova SBE Health Economics &amp; Management Knowledge Center</strong>&nbsp;presents&nbsp;<strong>𝐇𝐞𝐚𝐥𝐭𝐡𝐨𝐧𝐨𝐦𝐢𝐜𝐬 𝐓𝐚𝐥𝐤𝐬</strong>, a podcast dedicated to showcase the work developed in Health Economics at Nova...</p>
PAPER | Most Favored Nation Drug Pricing Means Anchoring To A Moving Target - <p>This article examines the likely consequences of adopting Most Favored Nation (MFN) drug pricing in the United States, a policy designed to tie US drug prices to the lowest prices observed in selected...</p>
14 | April 2026 | Chronic disease: demographic inevitability or structural change? An analysis of trends in the prevalence of chronic diseases in Portugal (2017–2025) - <p>This Short Note&nbsp;analyses trends in the prevalence of chronic diseases in Portugal between 2017 and 2025, seeking to determine to what extent the observed increase is due to population aging or to...</p>
PAPER | The Impact of Health Technology Assessment on Pharmaceutical Prices: Evidence from Germany - <p>This study evaluates the causal impact of Germany&rsquo;s 2011 AMNOG reform, which introduced a formal Health Technology Assessment (HTA)-based system requiring price negotiations for new drugs based...</p>
PAPER | Dynamic and heterogeneous impacts of granting and revoking elective c-section rights in São Paulo - <p>This study examines the effects of a unique natural experiment in São Paulo, Brazil, where a 2019 law temporarily allowed pregnant women to opt for elective caesarean sections in public healthcare...</p>
How to build better partnerships with people with illness in health research? - <p>This Short Note addresses the question of how to build better partnerships with patients in health research, proposing a new conceptual framework that systematically defines three distinct levels of...</p>
WORKING PAPER | On the Long-Run Effects of "Most Favored Nation" Drug Pricing - <p>A new working paper explores the long-run implications of &ldquo;Most Favored Nation&rdquo; (MFN) drug pricing, a policy increasingly debated in international pharmaceutical markets.</p>
New European Commission Study | Biosimilars - <p>A new European Commission report reinforces the role of biosimilars in improving access and supporting the sustainability of healthcare systems across Europe.</p>
Podcast Saúde em Perspetiva (Health in Perspective) - <p data-end="31" data-start="0"><strong data-end="31" data-start="0">Saúde em Perspetiva&nbsp;</strong>is the podcast of the <strong data-end="116" data-start="57">Nova SBE Health Economics &amp; Management Knowledge Center</strong>, dedicated to the major challenges facing health in Portugal. The project is organised into...</p>
Short Notes | March 2026 | Family doctors in the private sector in Portugal – current situation - <p>This Short Note assesses whether the use of family doctors in the private sector in Portugal is solely due to a lack of access to family doctors in the National Health Service (NHS), or whether it...</p>
1
2
3
4
5
6
7
8
9